Document Detail


Changes in compulsion and anxiety symptoms with nicotine transdermal patches in non-smoking obsessive-compulsive disorder patients.
MedLine Citation:
PMID:  15011734     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Some of the obsessive-compulsive disorder (OCD) symptoms can be elicited in rats by the administration of quinpirole (D2/D3 dopaminergic agonist). Nicotine administration blocked some aspect of checking behavior in that model. The main goal of this study was to determine if the clinical manifestations of OCD non smoking patients change with the administration of transdermal nicotine patches. MATERIAL AND METHODS: Eleven patients were studied (6 female and 5 males), average age 29.7 +/- 5.5 years. All of them were OCD according to DSM-IV criteria. Clinical scorings were done with Yale-Brown Obsessive Compulsive Scale (Y-BOCS), Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI). Nicotine (17.5 mg/day) or placebo transdermal patches were randomly administered for five continuous days. RESULTS: Nicotine administration reduced the total Y-BOCS and the compulsive score of that scale, but did not reduce obsessions. Also anxiety was reduced as was shown by the BAI scores, when patients were on nicotine patches, no changes were observed in BDI. CONCLUSIONS: The present results replicated the animal findings about reduction in compulsive behavior after nicotine administration. Also suggest that nicotine depending on the dysfunction of the different neurotransmitter systems may produce different behavior or cognitive effects, also that even nicotine showed some beneficial effect in OCD patients, the low rate of nicotine smoking in this type of patients, may show other mechanisms than may protect to smoke in some psychiatric patients.
Authors:
Rafael J Salín-Pascual; Elizabeth Basañez-Villa
Related Documents :
345824 - The unmotivated patient syndrome: survey of therapeutic interventions.
9108814 - Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and r...
18458724 - Level of agitation of psychiatric patients presenting to an emergency department.
10500384 - The right to refuse psychiatric treatment in kentucky.
17045904 - Pre-operative computed tomography coronary angiography to detect significant coronary a...
22870564 - A cost effective complement to managing the vitamin d deficient and anemic dialysis pat...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición     Volume:  55     ISSN:  0034-8376     ISO Abbreviation:  Rev. Invest. Clin.     Publication Date:    2003 Nov-Dec
Date Detail:
Created Date:  2004-03-11     Completed Date:  2004-06-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9421552     Medline TA:  Rev Invest Clin     Country:  Mexico    
Other Details:
Languages:  eng     Pagination:  650-4     Citation Subset:  IM    
Affiliation:
Departamento de Neurología y Psiquiatría, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México, DF. salin@servidor.unam.mx
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Cutaneous
Adolescent
Adult
Anxiety / prevention & control*
Child
Female
Humans
Male
Nicotine / administration & dosage*
Nicotinic Agonists / administration & dosage*
Obsessive-Compulsive Disorder / prevention & control*
Chemical
Reg. No./Substance:
0/Nicotinic Agonists; 54-11-5/Nicotine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Construction and validation of a clinical diagnostic-therapeutic guide for the hospitable management...
Next Document:  Comparative analysis of the influence of food and cimetidine in plasma levels of praziquantel